December 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreMarch 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreNovember 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreNovember 01, 2025
Projections indicate that, the global biological safety testing market will increase from USD 5.43 billion in 2024 to USD 15.07 billion by 2034, experiencing a CAGR of 10.75% over the next 10 years. The Growing concern regarding the safety of products in the pharma and biotech industry drives the growth of the market....
November 01, 2025
Projections indicate that, the global aseptic sampling market will increase from USD 1.02 billion in 2024 to USD 2.31 billion by 2034, experiencing a CAGR of 7.76% over the next 10 years. The growing prevalence of chronic conditions demand for pharmaceuticals and biotechnology products, which increases the usage of aseptic sampling procedures....
November 01, 2025
Based on market forecasts, the automated cell counting sector will expand from USD 4.48 billion in 2024 to USD 14.51 billion by 2034, experiencing a CAGR of 12.48%. Cell counting is needed in cell culture applications, monitoring of cell culture, development of cell-based assays, and many other processes associated with cell counting, which promote...
November 01, 2025
According to market estimations, the pharmaceutical water market is projected to grow at a robust CAGR of 9.25% from 2024 to 2034. North America led with a 35% market share in 2023, while Asia Pacific is anticipated to expand at the fastest rate of 10.34% during the forecast period. In 2023, water for injection dominated the market with a 79% share...
November 01, 2025
Based on market forecasts, the global perfusion systems market, projected at USD 1.21 billion in 2024, is expected to reach USD 1.94 billion by 2034, growing at a CAGR of 4.85% over the forecast period. The increasing incidence of cardiovascular, respiratory, and renal disorders and awareness of organ donation drive the perfusion systems market....
November 01, 2025
Projections indicate that, recombinant lysyl endopeptidase industry is projected to rise from USD 40.01 million in 2024 to USD 67.06 million by 2034, reflecting a CAGR of 5.3% over the next decade. The rising demand for proteomics and genetic engineering, increasing investments, and rising chronic illnesses drive the market....
November 01, 2025
According to market projections, the nonspecific endonuclease market size to capture US$ 424.58 mn in 2025 and is to soar US$ 641.37 mn by 2030. The nonspecific endonuclease market is growing, driven by demand in gene therapy and genetic engineering, especially in North America and Asia Pacific. Used for DNA/RNA cleavage in research and therapy, th...
November 01, 2025
Projections indicate that, the global gene synthesis service market will increase from USD 681.53 million in 2024 to USD 3138.64 million by 2034, experiencing a CAGR of 16.5% over the next 10 years. The rising incidences of chronic disorders, increasing demand for genomics, and growing research & development drive the market....
November 01, 2025
The sterile antimicrobial gel market dominated by silver dressings, is driven by demand for chronic wound care, especially for ulcers. Hospitals lead end-user adoption due to advanced wound care technologies, while public health concerns boost demand for chronic wound solutions, supporting market growth....
November 01, 2025
Core clinical molecular diagnostics applies molecular biology techniques to study diseases like cancer and infections, focusing on patient care. With the aging population increasing chronic disorders, the demand for biomarker analysis grows. Advancements in genomics and proteomics, along with a push for personalized medicine, further drive the mark...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com